Smoking reduces life expectancy by approximately 10 years and accelerates biological aging by 7–10 years as measured by epigenetic clocks, but cessation at any age produces rapid and substantial health benefits.
Smoking reduces life expectancy by approximately 10 years. Smokers who quit by age 40 regain almost all of this lost life expectancy; those who quit by 30 regain essentially all of it. Smoking accelerates epigenetic aging by 7–10 years and is causally linked to at least 15 types of cancer, cardiovascular disease, COPD, and stroke.
The British Doctors Study (Doll et al., 2004), following 34,439 British male doctors for 50 years, found that smokers died on average 10 years earlier than non-smokers. Those who stopped at age 60, 50, 40, or 30 gained approximately 3, 6, 9, or 10 years of life expectancy respectively. Jha et al. (2013) in the NEJM, using US data from 216,917 adults, confirmed that smoking accounted for 25% of all deaths in men and 21% in women aged 35–69. Levine et al. (2015) demonstrated that current smokers had epigenetic ages 7–10 years older than their chronological age, with partial reversal in former smokers.
"Smokers who stopped at age 40 gained approximately 9 years of life expectancy compared to those who continued smoking."
— Doll et al., BMJ 2004
Smoking reduces life expectancy by approximately 10 years. Smokers who quit by age 40 regain almost all of this lost life expectancy; those who quit by 30 regain essentially all of it. Smoking accelerates epigenetic aging by 7–10 years and is causally linked to at least 15 types of cancer, cardiovascular disease, COPD, and stroke.
The British Doctors Study (Doll et al., 2004), following 34,439 British male doctors for 50 years, found that smokers died on average 10 years earlier than non-smokers. Those who stopped at age 60, 50, 40, or 30 gained approximately 3, 6, 9, or 10 years of life expectancy respectively. Jha et al. (2013) in the NEJM, using US data from 216,917 adults, confirmed that smoking accounted for 25% of all deaths in men and 21% in women aged 35–69. Levine et al. (2015) demonstrated that current smokers had epigenetic ages 7–10 years older than their chronological age, with partial reversal in former smokers.
"Smokers who stopped at age 40 gained approximately 9 years of life expectancy compared to those who continued smoking."
— Doll et al., BMJ 2004
MedlinePlus identifies smoking as the leading preventable cause of death in the United States, responsible for more than 480,000 deaths per year. The NIA notes that smoking is a major risk factor for heart disease, stroke, lung disease, and cancer, and that quitting at any age produces health benefits. The CDC recommends nicotine replacement therapy (patches, gum, lozenges), prescription medications (varenicline, bupropion), and behavioural support as the most effective cessation strategies.
Quitting smoking is the single most impactful health intervention available to smokers, regardless of age. Combination therapy — nicotine replacement plus varenicline plus behavioural support — produces the highest quit rates (approximately 25–35% sustained abstinence at 12 months). Within 20 minutes of quitting, blood pressure and heart rate normalise. Within 1 year, excess cardiovascular risk falls by 50%. Within 10 years, lung cancer risk falls to approximately half that of a continuing smoker. There is no 'safe' level of smoking — even 1–4 cigarettes per day is associated with significantly elevated cardiovascular and cancer risk.
Vitaei verdict
Smoking is the most powerful modifiable determinant of longevity. Quitting at any age produces rapid and substantial health benefits. Combination pharmacotherapy plus behavioural support is the most effective cessation approach.